The decline in incidence continues in Spain and is already close to going from extreme to high risk values, below 250 cases. This Friday it was located at 264.13, a decrease of 12.3 points compared to the situation on Thursday. The incidence falls in all the autonomous communities and only rises in Ceuta.
The Ministry of Health has reported 9,489 new infections in the last 24 hours. This is an increase compared to the previous day, when 7,115 positives were registered. In total, 4,831,809 people have been infected with COVID since the start of the pandemic.
The communities that register the highest number of new cases in the last hours are Andalusia, which records 1,832 infections; Madrid, which totals 1,449; Catalunya, which adds 1,444; and the Valencian Community, with 854.
The authorities have informed in the last daily report of 139 deaths registered in the last day. The global death toll since the start of the pandemic stands at 84,000.
It also lowers the pressure in hospitals. UCI occupancy fell to 18.37%, a few tenths below that of Thursday, with Catalonia and Madrid still above 30%. Murcia, Galicia and Asturias, on the other hand, are below the 10% occupancy barrier.
As for those hospitalized for COVID in conventional beds, the occupancy drops to 6.15%. In total, there are 7,368 patients, after the 867 discharges registered on the last day.
Meanwhile, communities have already administered more than 65 million doses of some of the available COVID vaccines since the start of the campaign in December 2020.
With this, 68.4% of the population already has the complete regimen, that is, two doses of Pfizer, Moderna or AstraZeneca or one of Janssen, plus 32.5 million people. In addition, 36.2 million have at least one first puncture, 76.4% of the inhabitants.
In the last 24 hours, the communities have put a total of 321,489 doses of any of the available vaccines.
By age, 91.8% of those over 40 already have the full regimen and 94.1% have received at least the first injection. In addition, more than half of the young people between 20 and 29 years of age have the complete regimen and 71.8%, at least the first dose. The next group, from 12 to 19, already touches 70% of those vaccinated with the first dose, although only 22.4% of them have the complete schedule necessary to obtain maximum immunity.
Trials of the Spanish vaccine against COVID advance with the first doses in humans
The first group of volunteers participating in Phase I / IIa of the trials of the vaccine against COVID-19 of the Catalan pharmaceutical company Hipra have already received the first doses. In total, around 500 volunteers between the ages of 18 and 39 will collaborate in this clinical stage of the study, where the safety of what could be the first Spanish vaccine against the disease caused by the coronavirus will mainly be verified.
Two weeks after the announcement by the Spanish Agency for Medicines and Health Products (AEMPS) that they were giving the green light to human trials of the drug, the Catalan company Hipra has begun to inoculate the product to the first 30 volunteers at the Hospital Universitario Clínic Barcelona and the Doctor Josep Trueta University Hospital of Girona. In addition to the injection, participants must fill out a questionnaire and take a blood test to know for sure that they have not previously passed COVID-19, one of the requirements – in addition to not being vaccinated – to participate in the tests. Informs Africa Gelardo Arrebola.